Introduction to the Cell Research Center
The REV-MED Cell Research Center was established in 2018 and conducts research focused on cell differentiation, regeneration, and immune modulation to explore technologies that can support the treatment of various diseases and anti-aging solutions. The center concentrates on the research of blood cells, bone marrow cells, and adipose cells, striving to develop innovative regenerative medicine technologies that could assist in the regeneration of damaged tissues and degenerative conditions, aiming to improve people's quality of life.
Through its cell separation and culture techniques, the center efficiently expands pure cells, enabling large-scale clinical applications. Additionally, the center monitors cell growth in real-time using cell growth observation technologies and fluorescence-labeled target cells for analysis. This ensures precise quality control and facilitates swift recovery support.
The REV-MED Cell Research Center collaborates with domestic and international researchers to expand its capabilities and plays a leading role in the development of pharmaceuticals and medical devices in the regenerative medicine field. The center will continue researching various cell technologies to find ways that may support treatments for diseases and improve patient outcomes.
Key Research and Development Projects
The Cell Research Center leads the development of regenerative medicine and biotechnology technologies through various research projects, focusing particularly on therapies using blood cells, adipose cells, and bone marrow cells.
- Study on the Use of Autologous Concentrates for Rotator Cuff Tear Treatment This project investigates the potential of using autologous blood concentrates to assist in tissue regeneration for patients with rotator cuff tears. Using PRP (Platelet-Rich Plasma) and other autologous concentrates, the study aims to evaluate the possibility of tissue reinforcement, supporting the recovery process, and reducing the risk of re-injury. This project is supported by the Korea Health Industry Development Institute.
- Development of a Platelet-Derived Exosome Concentration Kit The center is developing technology to concentrate platelet-derived exosomes in collaboration with Incheon University. Exosomes play a crucial role in intercellular communication and can assist in tissue regeneration. This project is supported by the Korea Industrial Complex Corporation, and it aims to explore the potential to enhance the effectiveness of regenerative therapies through concentrated exosomes.
- Intranasal PRP Injection for Olfactory Dysfunction After Acute Upper Respiratory Infection This study investigates the potential of using PRP nasal injections to support the recovery of olfactory function in patients suffering from olfactory dysfunction after an acute upper respiratory infection. PRP may help regenerate the nasal mucosa, and the project is supported by the Seongnam Industry Promotion Agency.
Product Development and Patents
- DuoCell-SVF The DuoCell-SVF kit isolates stromal vascular fraction (SVF) from adipose tissue, which has a wide range of clinical applications. The kit efficiently extracts cells from adipose tissue and may assist in tissue regeneration. The product was patented and registered in 2017 and has also been certified.
- PRP UNI This small-volume PRP separation kit is suitable for simple procedures and is widely used in both orthopedics and aesthetic fields. It was patented in 2021, and the product is currently in use in numerous medical institutions.
- NovaStem BC & BMAC An improved version of existing PRP and bone marrow concentrate (BMC) kits, this product enhances user convenience with its needle-free (Needless) design. The product is currently undergoing certification, and test results have been positive.
- Platelet-Derived Exosome Concentration Kit (NovaExo) The NovaExo kit concentrates platelet-derived exosomes, with proven potential to support tissue regeneration. Developed in collaboration with Incheon University, the product was patented and registered in 2022.
The Cell Research Center is continuously developing various products and is conducting research to enhance product performance by applying graphene materials to next-generation products. These products are expected to lead significant advancements in the regenerative medicine field.
Introduction to the Cell Research Center
The REV-MED Cell Research Center was established in 2018 and conducts research focused on cell differentiation, regeneration, and immune modulation to explore technologies that can support the treatment of various diseases and anti-aging solutions. The center concentrates on the research of blood cells, bone marrow cells, and adipose cells, striving to develop innovative regenerative medicine technologies that could assist in the regeneration of damaged tissues and degenerative conditions, aiming to improve people's quality of life.
Through its cell separation and culture techniques, the center efficiently expands pure cells, enabling large-scale clinical applications. Additionally, the center monitors cell growth in real-time using cell growth observation technologies and fluorescence-labeled target cells for analysis. This ensures precise quality control and facilitates swift recovery support.
The REV-MED Cell Research Center collaborates with domestic and international researchers to expand its capabilities and plays a leading role in the development of pharmaceuticals and medical devices in the regenerative medicine field. The center will continue researching various cell technologies to find ways that may support treatments for diseases and improve patient outcomes.
Key Research and Development Projects
The Cell Research Center leads the development of regenerative medicine and biotechnology technologies through various research projects, focusing particularly on therapies using blood cells, adipose cells, and bone marrow cells.
Product Development and Patents
The Cell Research Center is continuously developing various products and is conducting research to enhance product performance by applying graphene materials to next-generation products. These products are expected to lead significant advancements in the regenerative medicine field.